Novo Nordisk says completes hemophilia drug trial
COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a he...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/fAjdWawZyv8/story01.htm
No comments:
Post a Comment